A U.S. Registry of Eosinophilic Esophagitis Adolescent and Adult Patients Treated With DUPIXENT® As Standard of Care
Recruitment Status: Recruiting
Start Date: November 22, 2024
End Date: May 09, 2030
Inclusion Criteria:
1. Initiating treatment with DUPIXENT® for EoE according to the USPI
2. Able to understand and complete registry-related questionnaires (including adolescents) Key
Exclusion Criteria:
1. Patients who have a contraindication to DUPIXENT® according to the USPI
2. Treatment with DUPIXENT® within the 6 months prior to the screening assessment
3. Participation in an ongoing interventional study on or within 6 months of the baseline assessment. Once enrolled in registry, participation is allowed in other ongoing studies (at the discretion of the registry investigator) NOTE: Other protocol defined inclusion/exclusion criteria apply
-
Conditions:
- Esophagitis
- Eosinophilic Esophagitis